MSB 4.69% $1.45 mesoblast limited

Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-827

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 5,491 Posts.
    lightbulb Created with Sketch. 8962
    I think you are too presumptuous to the point of being offensive.

    When did I ever suggest I was being twitchy with my holding?

    What I said prior to the ODAC meeting was factual, the FDA’s position was exactly as I said. They repeated their position at the meeting.

    I didn’t say anything about selling, in fact after considering all that I read I concluded it would still be a positive vote.

    Maybe it was you who got twitchy prior to the ODAC meeting after reading other people’s research and mistook that as those providing you with the facts as getting twitchy?
    Last edited by stockrock: 28/09/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.